The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 2012

Wednesday, October 03, 2012

Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 201210:33 EDT Wednesday, October 03, 2012BEDFORD, Mass., Oct. 3, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its fourth quarter fiscal 2012 operating results on Monday, November 12, 2012 after market close. In conjunction with the release, management will host a conference call on Monday, November 12, 2012, at 5:00 p.m. (Eastern).Interested participants may listen to the call by dialing 877-856-1958 or 719-325-4810 for international callers and referencing code 9845290 approximately 15 minutes prior to the call on November 12th. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through Friday, November 30, 2012, at 888-203-1112 or 719-457-0820 for international callers, access code 9845290.The Company will also provide a live webcast of the call. Interested participants may access the webcast on the Company's website at www.hologic.com/investors-overview. A replay of the call will be archived on the Company's website and a PowerPoint presentation related to the conference call will be posted to the site after market close on Monday, November 12, 2012. About Hologic, Inc. Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com. Contacts:Deborah R. Gordon  Al KildaniVice President, Investor Relations Senior Director, Investor Relations (781) 999-7716  (858) 410-8653deborah.gordon@hologic.com   al.kildani@hologic.com SOURCE Hologic, Inc.